- Home
- LIQT vs IMRN Comparison
LIQT vs IMRN Comparison
Compare LIQT & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIQT
- IMRN
- Stock Information
- Founded
- LIQT 2004
- IMRN 1994
- Country
- LIQT Denmark
- IMRN Australia
- Employees
- LIQT N/A
- IMRN N/A
- Industry
- LIQT Industrial Machinery/Components
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- LIQT Technology
- IMRN Health Care
- Exchange
- LIQT Nasdaq
- IMRN Nasdaq
- Market Cap
- LIQT 14.0M
- IMRN 15.0M
- IPO Year
- LIQT N/A
- IMRN N/A
- Fundamental
- Price
- LIQT $1.53
- IMRN $1.81
- Analyst Decision
- LIQT Strong Buy
- IMRN Strong Buy
- Analyst Count
- LIQT 2
- IMRN 1
- Target Price
- LIQT $5.58
- IMRN $5.00
- AVG Volume (30 Days)
- LIQT 14.5K
- IMRN 6.2K
- Earning Date
- LIQT 11-14-2024
- IMRN 11-26-2024
- Dividend Yield
- LIQT N/A
- IMRN N/A
- EPS Growth
- LIQT N/A
- IMRN N/A
- EPS
- LIQT N/A
- IMRN N/A
- Revenue
- LIQT $15,128,295.00
- IMRN $3,271,194.00
- Revenue This Year
- LIQT $5.96
- IMRN N/A
- Revenue Next Year
- LIQT $32.89
- IMRN N/A
- P/E Ratio
- LIQT N/A
- IMRN N/A
- Revenue Growth
- LIQT N/A
- IMRN 171.67
- 52 Week Low
- LIQT $1.52
- IMRN $1.59
- 52 Week High
- LIQT $3.75
- IMRN $5.96
- Technical
- Relative Strength Index (RSI)
- LIQT 33.32
- IMRN 35.96
- Support Level
- LIQT $1.82
- IMRN $1.73
- Resistance Level
- LIQT $1.99
- IMRN $1.99
- Average True Range (ATR)
- LIQT 0.14
- IMRN 0.12
- MACD
- LIQT 0.00
- IMRN 0.02
- Stochastic Oscillator
- LIQT 2.72
- IMRN 20.42
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.